On 30 MAY Valeant Pharmaceuticals Intl Inc (NYSE:VRX) said it would boost its takeover bid for Botox-maker Allergan Inc for the second time this week, contingent on the two sides negotiating. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) net profit margin is -13.10% and weekly performance is 1.95%. On last trading day company shares ended up $121.93. Analysts mean target price for the company is $52.38. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) distance from 50-day simple moving average (SMA50) is -4.80%.
On 20 JUNE Alkermes Plc (NASDAQ:ALKS) reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.01. The company had revenue of $130.21 million for the quarter, compared to the consensus estimate of $135.79 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was down 20.3% on a year-over-year basis. On average, analysts predict that Alkermes Plc will post $0.49 earnings per share for the current fiscal year. Alkermes Plc (NASDAQ:ALKS) shares advanced 5.71% in last trading session and ended the day on $50.88. ALKS Gross Margin is 69.30% and its return on assets is -0.40%. Alkermes Plc (NASDAQ:ALKS) quarterly performance is 9.49%.
On 20 JUNE Flamel Technologies S.A. (ADR) (NASDAQ:FLML) reported ($0.94) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.15) by $0.79. The company had revenue of $9.20 million for the quarter, compared to the consensus estimate of $7.47 million. During the same quarter last year, the company posted ($0.35) earnings per share. On average, analysts predict that Flamel Technologies S.A. will post $-0.01 earnings per share for the current fiscal year. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) shares moved up 18.79% in last trading session and was closed at $15.17, while trading in range of $12.61 – $15.75. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) year to date (YTD) performance is 88.45%.
On 27 MAY Petmed Express Inc (NASDAQ:PETS) reported a mixed fourth-quarter fiscal 2014 with better-than-expected earnings per share (EPS) and a revenue miss. This nationwide pet pharmacy presently carries a Zacks Rank #3 (Hold). Petmed Express Inc (NASDAQ:PETS) ended the last trading day at $13.25. Company weekly volatility is calculated as 1.92% and price to cash ratio as 7.91. Petmed Express Inc (NASDAQ:PETS) showed a negative weekly performance of -0.38%.
On 5 JUNE Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.05) by $0.03. On average, analysts predict that Acura Pharmaceuticals will post $-0.16 earnings per share for the current fiscal year. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) weekly performance is 2.88%. On last trading day company shares ended up $1.07. Analysts mean target price for the company is $1.75. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) distance from 50-day simple moving average (SMA50) is -11.32%.